Document is current
Any future updates will be listed below
-
Authors
Bayó, Cristina https://orcid.org/0000-0002-7077-6213
Castellano, Giancarlo
Marín, Fátima
Castillo-Iturra, Joaquín
Ocaña, Teresa
Kumari, Hardeep
Pellisé, Maria
Moreira, Leticia
Rivero, Liseth
Daca-Alvarez, Maria
Ortiz, Oswaldo
Carballal, Sabela
Moreira, Rebeca
Canet-Hermida, Julia
Pineda, Marta
Gabriel, Capella
Flórez-Grau, Georgina
Juan, Manel https://orcid.org/0000-0002-3064-1648
Benitez-Ribas, Daniel
Balaguer, Francesc
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01885702 at ClinicalTrials.govnct01885702 at ClinicalTrials.govDocuments that mention this clinical trial
Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies
https://doi.org/10.1136/jitc-2024-011177
nct05078866 at ClinicalTrials.govDocuments that mention this clinical trial
Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies
https://doi.org/10.1136/jitc-2024-011177
Documents that mention this clinical trial
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
https://doi.org/10.1136/jitc-2024-010419
1336 Final Ph1b/2 results for nous-209 monotherapy in lynch syndrome carriers: annual revaccination boosts T cell immunity informing future cancer interception strategies
https://doi.org/10.1136/jitc-2025-sitc2025.1336
Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies
https://doi.org/10.1136/jitc-2024-011177
Advances and challenges in cancer immunoprevention and immune interception
https://doi.org/10.1136/jitc-2023-007815
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI19/01867; PI22/00470; ICI22/00063; CB16/12/00234)
Hospital Clínic de Barcelona (Contractes Clínic de Recerca “Emili Letang - Jo)
Agència de Gestió d’Ajuts Universitaris i de Recerca (2023SGR01112; PERIS_SuportGrups23, SLT028/23/00021)
Agencia Estatal de Investigación (Retos Investigación grant (PID2019-111254RB-I00 a)
- License Information
